Each year, more than eight million patients visit emergency departments in the United States with chest pain suggestive of myocardial ischemia. Yet, in around 75% of cases, objective evidence of unstable coronary syndrome is lacking after the initial clinical and ECG evaluation.

Accelerated diagnostic protocols using biochemical markers and near-patient testing strategies with the Stratus^® CS analyzer can help address this challenge. Consequently, hospital stays—and the cost to manage both ACS-positive and ACS-negative patients—can be reduced.

Fast, informative results

• Rapid turnaround time: 14 minutes to first result, and 4 minutes for each subsequent result
• A broad menu of tests to support better chest pain differentiation from a single sample, on a single run, on a single instrument

Easy-to-use in the Emergency Department, Coronary Care Unit, STAT Lab or Central Lab

• Simple operation for all skill levels: load sample, rotor, TestPak™ Cartridge(s)—and press Start
• System accepts blood directly from collection tube—no sample preparation, no manual dilutions
• Integrated centrifuge spins whole blood to plasma and automatically pipettes to test cartridges—no user manipulation needed

Efficient and cost-effective

• Eliminates manual intervention steps that prolong result turnaround
• Single use packaging for tests, calibrators, and diluents reduce reagent waste
• Select tests based on patient need—no fixed assay panels
• System Check (electronic QC) reduces liquid QC frequency requirements

Compliant

• Barcode readers and lockout features for near-patient testing compliance
• Fully compliant with OSHA Bloodborne Pathogens Preamble
• First to the market with a guideline acceptable troponin I assay with the low end precision to meet the 2012 ESC/ACC Guidelines

Extensive Support

• Onsite training
• Field service group
• Technical telephone support

Click below to learn more about each assay available on the Stratus CS analyzer.